Filing Flows › Invivyd (IVVD) › R&D spending
Invivyd (IVVD) R&D spending by quarter
Invivyd's R&D spending was $29.4M in Q2 2026 (second quarter 2026), -4% from Q1 2026. Over the last 7 quarters it ranged from $8.0M (Q3 2025) to $30.7M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $29.4M | -4% | +207% |
| Q1 2026 | $30.7M | +206% | +189% |
| Q4 2025 | $10.0M | +25% | -44% |
| Q3 2025 | $8.0M | -16% | — |
| Q2 2025 | $9.6M | -10% | — |
| Q1 2025 | $10.6M | -41% | — |
| Q4 2024 | $17.9M | — | — |
Q2 2026 at a glance
Invivyd, Q2 2026: revenue $14.3M (+21% year over year), operating margin -320.8%, net loss $44.4M, operating cash flow −$43.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Invivyd's R&D spending?
Invivyd's R&D spending was $29.4M in Q2 2026 (second quarter 2026), -4% from Q1 2026.
How has Invivyd's R&D spending changed?
Over the last 7 quarters it ranged from $8.0M (Q3 2025) to $30.7M (Q1 2026).